316 related articles for article (PubMed ID: 24702655)
1. Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders.
Valent P
Clin Exp Allergy; 2014 Jul; 44(7):914-20. PubMed ID: 24702655
[TBL] [Abstract][Full Text] [Related]
2. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
[TBL] [Abstract][Full Text] [Related]
3. Insect Sting Anaphylaxis-Or Mastocytosis-Or Something Else?
Golden DBK; Carter MC
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1117-1123. PubMed ID: 30961837
[TBL] [Abstract][Full Text] [Related]
4. Hymenoptera Allergy and Mast Cell Activation Syndromes.
Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.
Gülen T; Hägglund H; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches.
Valent P; Akin C; Gleixner KV; Sperr WR; Reiter A; Arock M; Triggiani M
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216696
[TBL] [Abstract][Full Text] [Related]
7. The problem of anaphylaxis and mastocytosis.
Müller UR; Haeberli G
Curr Allergy Asthma Rep; 2009 Jan; 9(1):64-70. PubMed ID: 19063827
[TBL] [Abstract][Full Text] [Related]
8. A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders.
Romantowski J; Górska A; Niedoszytko M; Gulen T; Gruchała-Niedoszytko M; Nedoszytko B; Lange M; Brockow K; Arock M; Akin C; Valent P
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535634
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.
Valent P; Akin C; Nedoszytko B; Bonadonna P; Hartmann K; Niedoszytko M; Brockow K; Siebenhaar F; Triggiani M; Arock M; Romantowski J; Górska A; Schwartz LB; Metcalfe DD
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261124
[TBL] [Abstract][Full Text] [Related]
10. Mast cell activation syndromes presenting as anaphylaxis.
Akin C
Immunol Allergy Clin North Am; 2015 May; 35(2):277-85. PubMed ID: 25841551
[TBL] [Abstract][Full Text] [Related]
11. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
12. The presence of mast cell clonality in patients with unexplained anaphylaxis.
Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
[TBL] [Abstract][Full Text] [Related]
13. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
Bonadonna P; Zanotti R; Pagani M; Bonifacio M; Scaffidi L; Olivieri E; Franchini M; Reccardini F; Costantino MT; Roncallo C; Mauro M; Boni E; Rizzini FL; Bilò MB; Marcarelli AR; Passalacqua G
J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788
[TBL] [Abstract][Full Text] [Related]
14. How to diagnose mast cell activation syndrome: practical considerations.
Romantowski J; Górska A; Lange M; Nedoszytko B; Gruchała-Niedoszytko M; Niedoszytko M
Pol Arch Intern Med; 2020 Apr; 130(4):317-323. PubMed ID: 32096778
[TBL] [Abstract][Full Text] [Related]
15. Mast cell activation syndromes: definition and classification.
Valent P
Allergy; 2013 Apr; 68(4):417-24. PubMed ID: 23409940
[TBL] [Abstract][Full Text] [Related]
16. Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction.
Valent P; Akin C
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1109-1114. PubMed ID: 30961836
[TBL] [Abstract][Full Text] [Related]
17. [Tryptase: A practical guide for the physician].
Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
Rev Med Interne; 2020 Nov; 41(11):748-755. PubMed ID: 32712042
[TBL] [Abstract][Full Text] [Related]
18. Fatal hymenoptera venom anaphylaxis by undetected clonal mast cell disorder: A better identification of high risk patients is needed.
Chatain C; Sedillot N; Thomas M; Pernollet M; Bocquet A; Boccon-Gibod I; Bouillet L; Leccia MT
Rev Med Interne; 2021 Dec; 42(12):869-874. PubMed ID: 34776279
[TBL] [Abstract][Full Text] [Related]
19. Added sensitivity of component-resolved diagnosis in hymenoptera venom-allergic patients with elevated serum tryptase and/or mastocytosis.
Michel J; Brockow K; Darsow U; Ring J; Schmidt-Weber CB; Grunwald T; Blank S; Ollert M
Allergy; 2016 May; 71(5):651-60. PubMed ID: 26836051
[TBL] [Abstract][Full Text] [Related]
20. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
Kačar M; Rijavec M; Šelb J; Korošec P
Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]